Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age (Q74170822)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2000

Language	Label	Description	Also known as
English	Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age	scientific article published on 01 May 2000

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

C Rose

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Kamby

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H T Mouridsen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Andersson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K A Møller

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Andersen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Munkholm

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Dombernowsky

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I J Christensen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

61

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

103-110

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942095%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

https://scigraph.springernature.com/pub.10.1023/a:1006460925986

0 references

Endocrine therapy of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical importance of intratumoral aromatase

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardization of steroid receptor assays in human breast cancer--III. Selection of reference material for intra- and inter-laboratory quality control.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Letter: Confidence limits in evaluating controlled therapeutic trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced recurrence-free survival after reduced doses of adjuvant chemotherapy in breast cancer: are groups selected after randomization comparable?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006460925986

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74170822&oldid=1962096894"